November 05, 2016
1 min read
Save

Patients with Tönnis grade 2 hip OA had significantly higher rate of conversion to THA

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Recently published results showed a significantly higher rate of conversion to total hip arthroplasty at 2-year follow-up among patients with Tönnis grade 2 osteoarthritis who underwent hip arthroscopy compared with matched cohorts of patients with Tönnis grade 0 or grade 1 hips.

Researchers collected data on patients who underwent hip arthroscopy between April 2008 and December 2012. Researchers matched 37 patients categorized with Tönnis grade 2 osteoarthritis (OA) with patients categorized with Tönnis grade 0 OA and Tönnis grade 1 OA according to age within 5 years, sex and BMI. Researchers recorded four patient-reported outcome scores, a VAS score for pain, patient satisfaction level and rates of revision hip arthroscopy and conversion to total hip arthroplasty (THA).

Results showed a significant improvement in patient-reported outcomes and VAS scores in all groups. Overall, 69.7% of patients in the Tönnis grade 0 group; 75.8% of patients in the Tönnis grade 1 group; and 65.4% of patients in the Tönnis grade 2 group had a good-to-excellent results. The groups had no significant differences in the mean change in patient-reported outcomes, VAS scores and patient satisfaction levels, researchers noted, as well as no significant difference in the rate of revision arthroscopy. Researchers found patients with Tönnis grade 2 hips had an odds ratio for conversion to THA of 7.73 vs. patients with Tönnis grade 0 hips and a ratio of 4.36 vs. patients with Tönnis grade 1 hips. – by Casey Tingle

 

Disclosures: Chandrasekaran reports no relevant financial disclosures. Please see the full study for a list of all other authors’ relevant financial disclosures.